Joanne Masterson
Concepts (293)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eosinophilic Esophagitis | 23 | 2024 | 325 | 6.720 |
Why?
| | Eosinophils | 17 | 2021 | 332 | 3.050 |
Why?
| | Eosinophilia | 9 | 2021 | 218 | 2.590 |
Why?
| | Epithelial Cells | 12 | 2024 | 1096 | 2.320 |
Why?
| | Claudins | 3 | 2024 | 25 | 2.020 |
Why?
| | Enteritis | 4 | 2022 | 103 | 1.780 |
Why?
| | MicroRNAs | 6 | 2024 | 692 | 1.490 |
Why?
| | Tight Junctions | 4 | 2024 | 76 | 1.450 |
Why?
| | Gastroesophageal Reflux | 5 | 2023 | 234 | 1.420 |
Why?
| | Esophagus | 11 | 2024 | 255 | 1.390 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2024 | 278 | 1.330 |
Why?
| | Gastritis | 3 | 2021 | 108 | 1.070 |
Why?
| | Esophagitis | 2 | 2018 | 67 | 1.070 |
Why?
| | Colitis | 8 | 2024 | 266 | 0.940 |
Why?
| | Keratins | 2 | 2024 | 173 | 0.880 |
Why?
| | Hypersensitivity | 4 | 2024 | 257 | 0.870 |
Why?
| | Oxidative Phosphorylation | 1 | 2024 | 193 | 0.830 |
Why?
| | Claudin-1 | 2 | 2019 | 15 | 0.750 |
Why?
| | Barrett Esophagus | 1 | 2023 | 149 | 0.690 |
Why?
| | Esophageal Mucosa | 2 | 2019 | 22 | 0.690 |
Why?
| | Intestines | 2 | 2021 | 357 | 0.660 |
Why?
| | Fibrosis | 3 | 2024 | 552 | 0.650 |
Why?
| | Ileitis | 4 | 2015 | 32 | 0.640 |
Why?
| | Eosinophil Peroxidase | 2 | 2018 | 7 | 0.630 |
Why?
| | Esophageal Neoplasms | 1 | 2023 | 321 | 0.620 |
Why?
| | Gastrointestinal Diseases | 2 | 2019 | 209 | 0.600 |
Why?
| | Disease Models, Animal | 12 | 2024 | 4295 | 0.580 |
Why?
| | Mice, Transgenic | 5 | 2024 | 2167 | 0.570 |
Why?
| | Ileum | 2 | 2015 | 119 | 0.560 |
Why?
| | Cell Differentiation | 2 | 2024 | 1991 | 0.560 |
Why?
| | Receptors, CCR3 | 2 | 2018 | 8 | 0.520 |
Why?
| | Macrophages | 1 | 2024 | 1547 | 0.510 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2017 | 165 | 0.510 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 152 | 0.500 |
Why?
| | Anti-Inflammatory Agents | 3 | 2014 | 496 | 0.490 |
Why?
| | Crohn Disease | 4 | 2015 | 243 | 0.480 |
Why?
| | Interleukin-33 | 1 | 2015 | 50 | 0.470 |
Why?
| | Vascular Remodeling | 1 | 2017 | 193 | 0.460 |
Why?
| | Inflammation | 7 | 2024 | 2837 | 0.460 |
Why?
| | Epithelium | 5 | 2019 | 313 | 0.450 |
Why?
| | Intestinal Mucosa | 7 | 2016 | 623 | 0.440 |
Why?
| | Acute Lung Injury | 3 | 2024 | 287 | 0.430 |
Why?
| | Mice | 21 | 2024 | 17787 | 0.410 |
Why?
| | Signal Transduction | 7 | 2019 | 5079 | 0.410 |
Why?
| | Animals | 27 | 2024 | 36940 | 0.400 |
Why?
| | Th1 Cells | 3 | 2024 | 143 | 0.400 |
Why?
| | Interleukin-5 | 1 | 2012 | 44 | 0.390 |
Why?
| | Humans | 46 | 2024 | 137585 | 0.390 |
Why?
| | Celiac Disease | 1 | 2015 | 294 | 0.370 |
Why?
| | Bone Morphogenetic Protein 4 | 2 | 2010 | 43 | 0.360 |
Why?
| | Leukocyte Count | 3 | 2021 | 329 | 0.340 |
Why?
| | Myeloid Cells | 2 | 2024 | 148 | 0.330 |
Why?
| | Cadherins | 3 | 2010 | 206 | 0.320 |
Why?
| | Asthma | 2 | 2021 | 2295 | 0.320 |
Why?
| | Regeneration | 1 | 2010 | 197 | 0.300 |
Why?
| | Cell Line, Transformed | 2 | 2019 | 145 | 0.280 |
Why?
| | Bromodeoxyuridine | 1 | 2007 | 79 | 0.280 |
Why?
| | Lung | 4 | 2018 | 4060 | 0.280 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2007 | 69 | 0.280 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2007 | 94 | 0.270 |
Why?
| | DNA, Neoplasm | 1 | 2007 | 164 | 0.270 |
Why?
| | Child | 18 | 2021 | 21935 | 0.270 |
Why?
| | Proton Pump Inhibitors | 3 | 2018 | 109 | 0.260 |
Why?
| | Hypoxia | 2 | 2024 | 1112 | 0.260 |
Why?
| | Male | 21 | 2024 | 67762 | 0.230 |
Why?
| | DNA Damage | 1 | 2007 | 420 | 0.230 |
Why?
| | Cell Cycle | 1 | 2007 | 601 | 0.220 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2024 | 52 | 0.220 |
Why?
| | Protein Processing, Post-Translational | 1 | 2007 | 465 | 0.220 |
Why?
| | Receptors, CCR7 | 2 | 2015 | 32 | 0.210 |
Why?
| | Child, Preschool | 9 | 2019 | 11074 | 0.210 |
Why?
| | Cell Hypoxia | 1 | 2024 | 226 | 0.210 |
Why?
| | Mice, Inbred C57BL | 8 | 2024 | 5757 | 0.210 |
Why?
| | Female | 21 | 2024 | 73304 | 0.210 |
Why?
| | Hypercapnia | 1 | 2023 | 53 | 0.200 |
Why?
| | Hidradenitis Suppurativa | 1 | 2022 | 9 | 0.200 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2024 | 243 | 0.200 |
Why?
| | Glycolysis | 1 | 2024 | 321 | 0.190 |
Why?
| | Biomarkers | 6 | 2024 | 4149 | 0.190 |
Why?
| | Mucosal-Associated Invariant T Cells | 1 | 2022 | 37 | 0.190 |
Why?
| | Bone Morphogenetic Proteins | 2 | 2016 | 135 | 0.190 |
Why?
| | Adolescent | 13 | 2019 | 21513 | 0.180 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2024 | 545 | 0.180 |
Why?
| | Dexamethasone | 3 | 2012 | 368 | 0.180 |
Why?
| | Immunoglobulin G | 2 | 2018 | 893 | 0.170 |
Why?
| | Biopsy | 4 | 2019 | 1129 | 0.170 |
Why?
| | Disease Progression | 3 | 2023 | 2757 | 0.170 |
Why?
| | Chemokines | 2 | 2024 | 228 | 0.160 |
Why?
| | GATA3 Transcription Factor | 2 | 2018 | 26 | 0.160 |
Why?
| | Homeostasis | 2 | 2021 | 621 | 0.160 |
Why?
| | Antibodies, Monoclonal | 3 | 2017 | 1430 | 0.150 |
Why?
| | Protein Stability | 1 | 2019 | 176 | 0.150 |
Why?
| | Cytokines | 4 | 2016 | 2085 | 0.150 |
Why?
| | Colonic Diseases | 1 | 2018 | 33 | 0.140 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2012 | 976 | 0.140 |
Why?
| | Nanoparticles | 3 | 2018 | 481 | 0.140 |
Why?
| | Respiratory Hypersensitivity | 1 | 2018 | 69 | 0.140 |
Why?
| | Microbiota | 2 | 2016 | 762 | 0.140 |
Why?
| | Cell Movement | 5 | 2018 | 967 | 0.140 |
Why?
| | Phenotype | 3 | 2022 | 3196 | 0.140 |
Why?
| | Case-Control Studies | 2 | 2023 | 3556 | 0.140 |
Why?
| | Proteomics | 1 | 2024 | 1111 | 0.140 |
Why?
| | Patient Reported Outcome Measures | 1 | 2021 | 402 | 0.140 |
Why?
| | Chemotactic Factors, Eosinophil | 1 | 2017 | 7 | 0.130 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2012 | 346 | 0.130 |
Why?
| | Electric Impedance | 1 | 2017 | 107 | 0.130 |
Why?
| | Chemokine CCL24 | 2 | 2019 | 12 | 0.130 |
Why?
| | Antibodies | 2 | 2017 | 410 | 0.130 |
Why?
| | Mucous Membrane | 3 | 2013 | 125 | 0.130 |
Why?
| | Gene Expression Regulation | 3 | 2019 | 2607 | 0.130 |
Why?
| | Gastrointestinal Tract | 1 | 2019 | 195 | 0.130 |
Why?
| | Gene Expression | 2 | 2023 | 1502 | 0.130 |
Why?
| | Smad Proteins | 1 | 2016 | 42 | 0.130 |
Why?
| | Mice, Knockout | 5 | 2024 | 3015 | 0.120 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2017 | 151 | 0.120 |
Why?
| | Probiotics | 1 | 2016 | 54 | 0.120 |
Why?
| | Adenocarcinoma | 1 | 2023 | 940 | 0.120 |
Why?
| | G(M1) Ganglioside | 1 | 2015 | 7 | 0.120 |
Why?
| | Inflammasomes | 1 | 2017 | 131 | 0.120 |
Why?
| | Colon | 1 | 2018 | 282 | 0.120 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2015 | 549 | 0.120 |
Why?
| | Peroxidase | 1 | 2015 | 175 | 0.120 |
Why?
| | Receptor, Adenosine A2B | 1 | 2015 | 43 | 0.120 |
Why?
| | RNA, Small Interfering | 1 | 2017 | 622 | 0.120 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 1040 | 0.120 |
Why?
| | Fibronectins | 1 | 2015 | 133 | 0.110 |
Why?
| | Cell Culture Techniques | 1 | 2017 | 363 | 0.110 |
Why?
| | Down-Regulation | 1 | 2017 | 657 | 0.110 |
Why?
| | Neutrophils | 2 | 2017 | 1238 | 0.110 |
Why?
| | Desmosomes | 1 | 2014 | 21 | 0.110 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2015 | 72 | 0.110 |
Why?
| | Mice, Inbred C3H | 2 | 2016 | 269 | 0.110 |
Why?
| | Constriction, Pathologic | 1 | 2015 | 245 | 0.110 |
Why?
| | Interleukin-13 | 1 | 2015 | 149 | 0.110 |
Why?
| | Dextran Sulfate | 3 | 2024 | 83 | 0.110 |
Why?
| | Permeability | 2 | 2011 | 161 | 0.110 |
Why?
| | Cell Adhesion Molecules | 1 | 2015 | 181 | 0.110 |
Why?
| | Bronchi | 1 | 2016 | 260 | 0.110 |
Why?
| | Trachea | 1 | 2016 | 237 | 0.110 |
Why?
| | Th2 Cells | 2 | 2018 | 176 | 0.110 |
Why?
| | RNA, Bacterial | 1 | 2015 | 190 | 0.110 |
Why?
| | Th17 Cells | 1 | 2015 | 108 | 0.110 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2017 | 351 | 0.100 |
Why?
| | Autophagy | 1 | 2016 | 284 | 0.100 |
Why?
| | beta-Defensins | 1 | 2013 | 21 | 0.100 |
Why?
| | Oxazolone | 1 | 2012 | 5 | 0.100 |
Why?
| | Collagen | 1 | 2015 | 452 | 0.100 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 2012 | 28 | 0.100 |
Why?
| | Mucositis | 1 | 2012 | 19 | 0.100 |
Why?
| | Inflammation Mediators | 1 | 2015 | 513 | 0.100 |
Why?
| | Adult | 8 | 2021 | 37929 | 0.100 |
Why?
| | Ischemia | 1 | 2015 | 409 | 0.100 |
Why?
| | Chemokine CCL19 | 1 | 2012 | 6 | 0.100 |
Why?
| | Peptides | 1 | 2018 | 985 | 0.100 |
Why?
| | Chemokine CCL21 | 1 | 2012 | 14 | 0.090 |
Why?
| | Pregnenediones | 1 | 2012 | 19 | 0.090 |
Why?
| | Killer Cells, Natural | 1 | 2015 | 449 | 0.090 |
Why?
| | Choristoma | 1 | 2012 | 21 | 0.090 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2015 | 385 | 0.090 |
Why?
| | Anti-Allergic Agents | 1 | 2012 | 46 | 0.090 |
Why?
| | Chemokine CCL11 | 1 | 2011 | 26 | 0.090 |
Why?
| | Herpesvirus 4, Human | 1 | 2012 | 166 | 0.090 |
Why?
| | Cells, Cultured | 2 | 2017 | 4193 | 0.090 |
Why?
| | Neoplasms | 1 | 2007 | 2671 | 0.090 |
Why?
| | Kidney Diseases | 1 | 2015 | 408 | 0.090 |
Why?
| | Neutrophil Infiltration | 1 | 2011 | 107 | 0.090 |
Why?
| | Fibroblasts | 1 | 2016 | 996 | 0.090 |
Why?
| | Nerve Growth Factors | 1 | 2011 | 79 | 0.090 |
Why?
| | Smad Proteins, Receptor-Regulated | 1 | 2010 | 2 | 0.090 |
Why?
| | Mice, Inbred Strains | 1 | 2011 | 409 | 0.090 |
Why?
| | Naphthalenes | 1 | 2010 | 60 | 0.080 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2012 | 209 | 0.080 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 152 | 0.080 |
Why?
| | Up-Regulation | 1 | 2012 | 843 | 0.080 |
Why?
| | T-Lymphocyte Subsets | 1 | 2012 | 417 | 0.080 |
Why?
| | Tumor Suppressor Proteins | 1 | 2011 | 327 | 0.080 |
Why?
| | Infant | 3 | 2018 | 9465 | 0.070 |
Why?
| | Flow Cytometry | 4 | 2015 | 1178 | 0.070 |
Why?
| | Kidney | 1 | 2015 | 1468 | 0.070 |
Why?
| | beta-Galactosidase | 1 | 2007 | 78 | 0.070 |
Why?
| | Monocytes | 2 | 2023 | 563 | 0.070 |
Why?
| | Interleukin-1 | 1 | 2011 | 965 | 0.070 |
Why?
| | Mesoderm | 1 | 2008 | 144 | 0.070 |
Why?
| | Matrix Metalloproteinases | 1 | 2007 | 95 | 0.060 |
Why?
| | Diagnosis, Differential | 3 | 2018 | 1483 | 0.060 |
Why?
| | Retrospective Studies | 4 | 2018 | 15657 | 0.060 |
Why?
| | Pneumonia | 2 | 2024 | 639 | 0.060 |
Why?
| | Chronic Disease | 1 | 2011 | 1793 | 0.060 |
Why?
| | Azoxymethane | 1 | 2024 | 20 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 1 | 2010 | 2486 | 0.060 |
Why?
| | Culture Media, Conditioned | 1 | 2024 | 110 | 0.050 |
Why?
| | T-Box Domain Proteins | 1 | 2024 | 98 | 0.050 |
Why?
| | Cellular Microenvironment | 1 | 2024 | 84 | 0.050 |
Why?
| | Cell Cycle Proteins | 1 | 2007 | 617 | 0.050 |
Why?
| | Genes, Mitochondrial | 1 | 2023 | 14 | 0.050 |
Why?
| | Cell Line | 3 | 2018 | 2847 | 0.050 |
Why?
| | Cell Proliferation | 2 | 2008 | 2475 | 0.050 |
Why?
| | Carcinogenesis | 1 | 2024 | 217 | 0.050 |
Why?
| | Esophagoscopy | 2 | 2016 | 209 | 0.050 |
Why?
| | Fluorescent Antibody Technique | 2 | 2015 | 390 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2691 | 0.050 |
Why?
| | Interleukin-1beta | 2 | 2017 | 372 | 0.050 |
Why?
| | Rats | 1 | 2010 | 5647 | 0.050 |
Why?
| | Carbon Dioxide | 1 | 2023 | 267 | 0.040 |
Why?
| | International Cooperation | 1 | 2021 | 198 | 0.040 |
Why?
| | Mice, Mutant Strains | 2 | 2012 | 298 | 0.040 |
Why?
| | Acute Disease | 2 | 2015 | 1007 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2024 | 778 | 0.040 |
Why?
| | Fatty Acids | 1 | 2023 | 443 | 0.040 |
Why?
| | Chemokine CCL26 | 1 | 2019 | 10 | 0.040 |
Why?
| | Cell Line, Tumor | 1 | 2007 | 3412 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2023 | 886 | 0.040 |
Why?
| | Endoscopy, Digestive System | 1 | 2019 | 136 | 0.040 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2024 | 1091 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2015 | 1242 | 0.040 |
Why?
| | Sensitivity and Specificity | 2 | 2013 | 1946 | 0.030 |
Why?
| | RNA Transport | 1 | 2017 | 23 | 0.030 |
Why?
| | GTP-Binding Proteins | 1 | 2018 | 161 | 0.030 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2017 | 98 | 0.030 |
Why?
| | Receptors, CCR2 | 1 | 2017 | 40 | 0.030 |
Why?
| | Middle Aged | 4 | 2021 | 33479 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2017 | 327 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2018 | 2833 | 0.030 |
Why?
| | Chloroquine | 1 | 2016 | 54 | 0.030 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2016 | 61 | 0.030 |
Why?
| | Hematopoiesis | 1 | 2017 | 192 | 0.030 |
Why?
| | Cell Communication | 1 | 2017 | 315 | 0.030 |
Why?
| | Immunity, Mucosal | 1 | 2016 | 97 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2019 | 956 | 0.030 |
Why?
| | Macaca mulatta | 1 | 2016 | 166 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2018 | 611 | 0.030 |
Why?
| | In Situ Nick-End Labeling | 1 | 2015 | 124 | 0.030 |
Why?
| | Disease Susceptibility | 1 | 2017 | 347 | 0.030 |
Why?
| | Respiratory System | 1 | 2016 | 157 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2015 | 138 | 0.030 |
Why?
| | Allergens | 1 | 2018 | 409 | 0.030 |
Why?
| | Keratinocytes | 1 | 2016 | 249 | 0.030 |
Why?
| | Young Adult | 3 | 2019 | 13209 | 0.030 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2014 | 156 | 0.030 |
Why?
| | Adoptive Transfer | 1 | 2015 | 219 | 0.030 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2015 | 100 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2015 | 375 | 0.030 |
Why?
| | Models, Animal | 1 | 2016 | 384 | 0.030 |
Why?
| | Lung Neoplasms | 1 | 2007 | 2526 | 0.030 |
Why?
| | Isoenzymes | 1 | 2015 | 304 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2015 | 601 | 0.030 |
Why?
| | Base Sequence | 1 | 2017 | 2181 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 2015 | 378 | 0.030 |
Why?
| | Eosinophil Granule Proteins | 1 | 2012 | 21 | 0.020 |
Why?
| | Expressed Sequence Tags | 1 | 2012 | 42 | 0.020 |
Why?
| | Lysophospholipase | 1 | 2012 | 10 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2015 | 1272 | 0.020 |
Why?
| | Blotting, Western | 1 | 2015 | 1226 | 0.020 |
Why?
| | Carboxylic Ester Hydrolases | 1 | 2012 | 19 | 0.020 |
Why?
| | Genes, Bacterial | 1 | 2012 | 164 | 0.020 |
Why?
| | Diet Therapy | 1 | 2012 | 37 | 0.020 |
Why?
| | Antigens, CD | 1 | 2015 | 521 | 0.020 |
Why?
| | Vimentin | 1 | 2012 | 52 | 0.020 |
Why?
| | Protein Binding | 1 | 2018 | 2224 | 0.020 |
Why?
| | Netrin-1 | 1 | 2011 | 15 | 0.020 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2012 | 136 | 0.020 |
Why?
| | Metagenome | 1 | 2012 | 147 | 0.020 |
Why?
| | Lymphoid Tissue | 1 | 2012 | 75 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2015 | 483 | 0.020 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2011 | 31 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2015 | 539 | 0.020 |
Why?
| | Genome, Bacterial | 1 | 2012 | 142 | 0.020 |
Why?
| | Gastric Mucosa | 1 | 2011 | 55 | 0.020 |
Why?
| | Remission Induction | 1 | 2012 | 288 | 0.020 |
Why?
| | Specimen Handling | 1 | 2012 | 183 | 0.020 |
Why?
| | Equipment Design | 1 | 2012 | 522 | 0.020 |
Why?
| | Glycoproteins | 1 | 2012 | 342 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2015 | 1250 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2012 | 686 | 0.020 |
Why?
| | Endoscopy | 1 | 2012 | 318 | 0.020 |
Why?
| | Models, Genetic | 1 | 2012 | 600 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 852 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2012 | 812 | 0.020 |
Why?
| | Quality of Life | 1 | 2021 | 2892 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2012 | 480 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2016 | 1317 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2016 | 697 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2011 | 1316 | 0.020 |
Why?
| | Adrenal Cortex Hormones | 1 | 2012 | 565 | 0.020 |
Why?
| | Immunologic Memory | 1 | 2010 | 353 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2012 | 1738 | 0.020 |
Why?
| | Prospective Studies | 1 | 2019 | 7604 | 0.020 |
Why?
| | Cytoskeleton | 1 | 2008 | 191 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2008 | 402 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2013 | 3284 | 0.010 |
Why?
| | Cell Survival | 1 | 2008 | 1120 | 0.010 |
Why?
| | Aged | 1 | 2021 | 23961 | 0.010 |
Why?
| | Models, Biological | 1 | 2008 | 1783 | 0.010 |
Why?
|
|
Masterson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|